DP
ZYME icon

Diadema Partners’s Zymeworks ZYME Stock Holding History

Diadema Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,400
Closed -$563K – 214
2025
Q4 		$563K Buy
+21,400
New +$467K 0.1% 110

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diadema Partners's ZYME Position: Q1 2026 in Review

Diadema Partners opened a new position in Zymeworks (ZYME) in Q1 2026: 142,132 shares worth $3.56M. The stake represents 0.61% of the portfolio and ranks #44 among its holdings.

211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Diadema Partners held 142,132 shares of Zymeworks worth $3.56M as of Q1 2026.
  • Zymeworks was a new Diadema Partners position in Q1 2026.
  • Zymeworks made up 0.61% of Diadema Partners's portfolio in Q1 2026, its #44 holding.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.